Clinical Trial Details
EORTC-1205-LCG
Back to Clinical Trials Database
EORTC randomized phase II study of pleurectomy/ decortication (P/D) preceded or followed by chemotherapy in patients with early stage malignant pleural mesothelioma
| Trial Status | Closed to Patient Entry |
|---|---|
| Dates |
Date of activation: 19-Sep-2016 Date Step1 close: 06-Dec-2021 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 64 - All Groups: 64 |
| Treatment |
Surgery, Drug Pemetrexed, Cisplatin, ModraDoc006 |
| Study Staff |
Jan Van Meerbeeck (Study Coordinator) , Universitair Ziekenhuis Antwerpen, Edegem Hadi Almidani (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Beatrice Fournier (Clinical Scientist) , EORTC Headquarters, Brussels Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels Livia Meirsman (Project Manager) , EORTC Headquarters, Brussels Ana Oliveira (Data Manager) , EORTC Headquarters, Brussels Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Lucy Sepulveda (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels Jelle Stans (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels Tina Verschuere (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels Yuliya Vostrikova (Clinical Data Expert) , EORTC Headquarters, Brussels |
| Type of cancer | Mesothelioma |
| Participating groups | EORTC Lung Cancer Group |
| Recruiting centers |
Erasmus MC (Rotterdam, Netherlands) Hopital Nord (APHM) (Marseille, France) National Cancer Institute - Cairo (Cairo, Egypt) The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands) Universitair Ziekenhuis Antwerpen (Edegem, Belgium) Universitair Ziekenhuis Gent (Gent, Belgium) |
| Protocol summary | http://clinicaltrials.gov/study/NCT02436733 |
| NCT number | NCT02436733 |
| Financial Support |
EORTC Group External Grant EORTC HQ |
